164 related articles for article (PubMed ID: 19020470)
1. Radiolabeled immunotherapy in non-Hodgkin's lymphoma treatment: the next step.
Otte A; van de Wiele C; Dierckx RA
Nucl Med Commun; 2009 Jan; 30(1):5-15. PubMed ID: 19020470
[TBL] [Abstract][Full Text] [Related]
2. Treatment of non-Hodgkin's lymphoma (NHL) with radiolabeled antibodies (mAbs).
DeNardo GL
Semin Nucl Med; 2005 Jul; 35(3):202-11. PubMed ID: 16098294
[TBL] [Abstract][Full Text] [Related]
3. Radioimmunotherapy for non-Hodgkin's lymphoma: a review for radiation oncologists.
Macklis RM; Pohlman B
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):833-41. PubMed ID: 16965871
[TBL] [Abstract][Full Text] [Related]
4. Radioimmunotherapy in non-Hodgkin's lymphoma: focus on 90Y-ibritumomab tiuxetan (Zevalin).
White CA
J Exp Ther Oncol; 2004 Dec; 4(4):305-16. PubMed ID: 15844660
[TBL] [Abstract][Full Text] [Related]
5. Perspectives on cancer therapy with radiolabeled monoclonal antibodies.
Sharkey RM; Goldenberg DM
J Nucl Med; 2005 Jan; 46 Suppl 1():115S-27S. PubMed ID: 15653660
[TBL] [Abstract][Full Text] [Related]
6. Development of radioimmunotherapy for the treatment of non-Hodgkin's lymphoma.
Multani P
Int J Hematol; 2002 Dec; 76(5):401-10. PubMed ID: 12512834
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic imaging prior to 90Y-ibritumomab tiuxetan (Zevalin) treatment in follicular non-Hodgkin's lymphoma.
Otte A
Hell J Nucl Med; 2008; 11(1):12-5. PubMed ID: 18392220
[TBL] [Abstract][Full Text] [Related]
8. Practical and clinical benefits of radioimmunotherapy lead to advantages in cost-effectiveness in the treatment of patients with non-Hodgkin's lymphoma.
Otte A; Thompson SL
Nucl Med Commun; 2006 Oct; 27(10):753-6. PubMed ID: 16969255
[No Abstract] [Full Text] [Related]
9. Radioimmunotherapy for indolent B-cell non-Hodgkin lymphoma in relapsed, refractory and transformed disease.
Visser OJ; Perk LR; Zijlstra JM; van Dongen GA; Huijgens PC; van de Loosdrecht AA
BioDrugs; 2006; 20(4):201-7. PubMed ID: 16831019
[TBL] [Abstract][Full Text] [Related]
10. Antibody therapy in non-Hodgkin's lymphoma: the role of rituximab, 90Y-ibritumomab tiuxetan, and alemtuzumab.
Fietz T; Thiel E
Recent Results Cancer Res; 2007; 176():153-63. PubMed ID: 17607923
[TBL] [Abstract][Full Text] [Related]
11. Radioimmunotherapy of non-Hodgkin's lymphoma: from the 'magic bullets' to 'radioactive magic bullets'.
Chamarthy MR; Williams SC; Moadel RM
Yale J Biol Med; 2011 Dec; 84(4):391-407. PubMed ID: 22180677
[TBL] [Abstract][Full Text] [Related]
12. Radioimmunotherapy of the Non-Hodgkin's Lymphomas.
Knox SJ
Semin Radiat Oncol; 1995 Oct; 5(4):331-341. PubMed ID: 10717155
[TBL] [Abstract][Full Text] [Related]
13. Antibody-guided radiation therapy of cancer.
Koppe MJ; Postema EJ; Aarts F; Oyen WJ; Bleichrodt RP; Boerman OC
Cancer Metastasis Rev; 2005 Dec; 24(4):539-67. PubMed ID: 16408161
[TBL] [Abstract][Full Text] [Related]
14. Radioimmunotherapy as the first line of treatment in non-Hodgkin lymphoma.
Eskian M; Khorasanizadeh M; Zinzani PL; Rezaei N
Immunotherapy; 2018 Jun; 10(8):699-711. PubMed ID: 29569511
[TBL] [Abstract][Full Text] [Related]
15. Radioimmunotherapy in non-Hodgkin lymphoma: Prediction and assessment of response.
Eskian M; Khorasanizadeh M; Kraeber-Bodere F; Rezaei N
Crit Rev Oncol Hematol; 2016 Nov; 107():182-189. PubMed ID: 27823646
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy for HIV-associated non-Hodgkin's lymphoma.
Newsom-Davis T; Ahamed E; Bower M
Expert Opin Biol Ther; 2009 Oct; 9(10):1313-24. PubMed ID: 19645631
[TBL] [Abstract][Full Text] [Related]
17. Radioimmunotherapy of B-cell NHL.
Meredith RF; Knox SJ
Curr Pharm Biotechnol; 2001 Dec; 2(4):327-39. PubMed ID: 11762414
[TBL] [Abstract][Full Text] [Related]
18. Defining the role of immunotherapy and radioimmunotherapy in the treatment of low-grade lymphoma.
Winter JN
Curr Opin Hematol; 2007 Jul; 14(4):360-8. PubMed ID: 17534162
[TBL] [Abstract][Full Text] [Related]
19. Radioimmunotherapy for non-Hodgkin's lymphoma.
Friedberg JW
Clin Cancer Res; 2004 Dec; 10(23):7789-91. PubMed ID: 15585609
[No Abstract] [Full Text] [Related]
20. Novel Methods to Improve the Efficiency of Radioimmunotherapy for Non-Hodgkin Lymphoma.
Eskian M; Khorasanizadeh M; Zinzani PL; Illidge TM; Rezaei N
Int Rev Immunol; 2019; 38(2):79-91. PubMed ID: 30931651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
